Lohman RJ - Search Results

1

Fabrication and Characterization of Clozapine Nanoemulsion Sol-Gel for Intranasal Administration.

Tan MSA, Pandey P, Lohman RJ, Falconer JR, Siskind DJ, Parekh HS. Tan MSA, et al. Among authors: lohman rj. Mol Pharm. 2022 Nov 7;19(11):4055-4066. doi: 10.1021/acs.molpharmaceut.2c00513. Epub 2022 Sep 23. Mol Pharm. 2022. PMID: 36149013

2

Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapy.

Lohman RJ, Reddy Tupally K, Kandale A, Cabot PJ, Parekh HS. Lohman RJ, et al. Front Pharmacol. 2023 Mar 3;14:1150313. doi: 10.3389/fphar.2023.1150313. eCollection 2023. Front Pharmacol. 2023. PMID: 36937883 Free PMC article.

3

An HDAC6 Inhibitor Confers Protection and Selectively Inhibits B-Cell Infiltration in DSS-Induced Colitis in Mice.

Do A, Reid RC, Lohman RJ, Sweet MJ, Fairlie DP, Iyer A. Do A, et al. Among authors: lohman rj. J Pharmacol Exp Ther. 2017 Jan;360(1):140-151. doi: 10.1124/jpet.116.236711. Epub 2016 Nov 8. J Pharmacol Exp Ther. 2017. PMID: 27827303

4

Novel helix-constrained nociceptin derivatives are potent agonists and antagonists of ERK phosphorylation and thermal analgesia in mice.

Harrison RS, Ruiz-Gómez G, Hill TA, Chow SY, Shepherd NE, Lohman RJ, Abbenante G, Hoang HN, Fairlie DP. Harrison RS, et al. Among authors: lohman rj. J Med Chem. 2010 Dec 9;53(23):8400-8. doi: 10.1021/jm101139f. Epub 2010 Nov 10. J Med Chem. 2010. PMID: 21067234

5

Antagonism of protease-activated receptor 2 protects against experimental colitis.

Lohman RJ, Cotterell AJ, Suen J, Liu L, Do AT, Vesey DA, Fairlie DP. Lohman RJ, et al. J Pharmacol Exp Ther. 2012 Feb;340(2):256-65. doi: 10.1124/jpet.111.187062. Epub 2011 Oct 25. J Pharmacol Exp Ther. 2012. PMID: 22028393

6

Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.

Lohman RJ, Harrison RS, Ruiz-Gómez G, Hoang HN, Shepherd NE, Chow S, Hill TA, Madala PK, Fairlie DP. Lohman RJ, et al. Vitam Horm. 2015;97:1-55. doi: 10.1016/bs.vh.2014.10.001. Epub 2015 Jan 14. Vitam Horm. 2015. PMID: 25677767 Review.

7

Differential Anti-inflammatory Activity of HDAC Inhibitors in Human Macrophages and Rat Arthritis.

Lohman RJ, Iyer A, Fairlie TJ, Cotterell A, Gupta P, Reid RC, Vesey DA, Sweet MJ, Fairlie DP. Lohman RJ, et al. J Pharmacol Exp Ther. 2016 Feb;356(2):387-96. doi: 10.1124/jpet.115.229328. Epub 2015 Dec 10. J Pharmacol Exp Ther. 2016. PMID: 26660228

8

Pharmacological inhibition of protease-activated receptor-2 reduces crescent formation in rat nephrotoxic serum nephritis.

Han Y, Tian L, Ma F, Tesch G, Vesey DA, Gobe GC, Lohman RJ, Morais C, Suen JY, Fairlie DP, Nikolic-Paterson DJ. Han Y, et al. Among authors: lohman rj. Clin Exp Pharmacol Physiol. 2019 May;46(5):456-464. doi: 10.1111/1440-1681.13077. Epub 2019 Mar 25. Clin Exp Pharmacol Physiol. 2019. PMID: 30811624

9

PAR2 Modulators Derived from GB88.

Yau MK, Liu L, Suen JY, Lim J, Lohman RJ, Jiang Y, Cotterell AJ, Barry GD, Mak JY, Vesey DA, Reid RC, Fairlie DP. Yau MK, et al. Among authors: lohman rj. ACS Med Chem Lett. 2016 Oct 10;7(12):1179-1184. doi: 10.1021/acsmedchemlett.6b00306. eCollection 2016 Dec 8. ACS Med Chem Lett. 2016. PMID: 27994760 Free PMC article.

10

Exploiting a novel conformational switch to control innate immunity mediated by complement protein C3a.

Lohman RJ, Hamidon JK, Reid RC, Rowley JA, Yau MK, Halili MA, Nielsen DS, Lim J, Wu KC, Loh Z, Do A, Suen JY, Iyer A, Fairlie DP. Lohman RJ, et al. Nat Commun. 2017 Aug 24;8(1):351. doi: 10.1038/s41467-017-00414-w. Nat Commun. 2017. PMID: 28839129 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page